Cleared Traditional

K201811 - coraForce and coraFlex Support Catheters

K201811 is an FDA 510(k) clearance for coraForce and coraFlex Support Catheters, manufactured by Reflow Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 117-day FDA review.

K201811 · Reflow Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2020
Decision
117d
Days
Class 2
Risk

K201811 is an FDA 510(k) clearance for the coraForce and coraFlex Support Catheters. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Reflow Medical, Inc. (San Clemente, US). The FDA issued a Cleared decision on October 26, 2020 after a review of 117 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Reflow Medical, Inc. devices

FDA 510(k) Submission Details - K201811

510(k) Number K201811 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2020
Decision Date October 26, 2020
Days to Decision 117 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 125d · This submission: 117d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 619
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K201811.
Recon Support Catheter
K203275 · C.R. Bard, Inc. · Mar 2021
Phenom Catheters
K210230 · Micro Therapeutics Lnc. D/B/A Ev3 Neurovascular · Feb 2021
Ventrax Delivery System
K202610 · Merit Medical Systems, Inc. · Dec 2020
Selectra 3D Outer Guiding Catheters
K193474 · Biotronik, Inc. · Oct 2020
ASAHI Corsair Armet 18 Microcatheter (Model: CSAR060-18N), ASAHI Corsair Armet 18 Microcatheter (Model: CSAR090-18N), ASAHI Corsair Armet 18 Microcatheter (Model: CSAR110-18N), ASAHI Corsair Armet 18 Microcatheter (Model: CSAR135-18N),
K202252 · Asahi Intecc Co., Ltd. · Sep 2020
NHancer Rx
K200324 · Imds Operations B.V. · Aug 2020